All
Foreign-Born Patients With HCC May Have Improved Survival Versus U.S.-Born Patients
May 25th 2023Patients born outside of the U.S. may have improved liver cancer survival rates compared with U.S.-born patients, although more research is needed to determine what may be driving this effect, research showed.
First U.S. Patient Treated in Study of Novel Drug-Chemo Combo for NSCLC Subset
May 23rd 2023Work is underway in the global phase 3 HARMONi study evaluating the combination of ivonescimab and chemotherapy in the treatment of patients with EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer.